IMUC Key Stats
PR Newswire11/14 06:00
|11/18/2014 17:00 EST||Misc||ImmunoCellular Therapeutics Ltd Business & Strategic Call in 2014|
|11/10/2014||Earnings||Q3 2014 Immunocellular Therapeutics Earnings Results|
|08/07/2014 17:00 EDT||Misc||Q2 2014 Immunocellular Therapeutics Earnings Conference Call|
|08/07/2014||Earnings||Q2 2014 Immunocellular Therapeutics Earnings Results|
|06/13/2014||Misc||Annual General Meeting for ImmunoCellular Therapeutics Ltd|
|05/08/2014 17:00 EDT||Misc||Q1 2014 ImmunoCellular Therapeutics, Ltd. Earnings Conference Call|
|05/08/2014||Earnings||Q1 2014 ImmunoCellular Therapeutics, Ltd. Earnings Results|
|03/13/2014 17:00 EDT||Misc||Q4 2013 ImmunoCellular Therapeutics, Ltd. Earnings Conference Call|
|03/13/2014||Earnings||Q4 2013 ImmunoCellular Therapeutics, Ltd. Earnings Results|
IMUC Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). ImmunoCellular is down 43.01% over the last year vs S&P 500 Total Return up 15.56%, Merrimack Pharmaceuticals up 75.56%, and Aratana Therapeutics down 14.08%.
Balance Sheet View Statement
Y-Ratings for IMUC
Portfolio Strategies Featuring IMUC
Did ImmunoCellular make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Company Website: http://www.imuc.com
- IR Website: http://investors.imuc.com/
- HQ Country: United States
- HQ State/Province: California
- Incorporation Country: United States
- Incorporation State/Province: Delaware
- Est. Current Fiscal Quarter End: March 31, 2015
- Est. Current Fiscal Year End: December 31, 2015
- Last Fiscal Quarter End: September 30, 2014
- Last Fiscal Year End: December 31, 2013
- Next Earnings Release: N/A
- NAICS: Research and Development in Biotechnology
- NAICS Code: 541711
- NAICS Industry: Scientific Research and Development Services
- NAICS Sector: Professional, Scientific, and Technical Services
ImmunoCellular Therapeutics Ltd is a clinical-stage biotechnology company that develops immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors.
IMUC Excel Add-In Codes
- Name: =YCI("IMUC","name")
- Description: =YCI("IMUC","description")
- Sector: =YCI("IMUC","sector")
- Industry: =YCI("IMUC","industry")
- Est. Current Fiscal Year End: =YCI("IMUC","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.